Ross Portaro
Sales & Marketing at VENUS CONCEPT INC.
Net worth: 6 868 $ as of 29/04/2024
Ross Portaro active positions
Companies | Position | Start | End |
---|---|---|---|
VENUS CONCEPT INC. | Sales & Marketing | 14/10/2021 | - |
Corporate Officer/Principal | 30/04/2021 | 14/10/2021 |
Career history of Ross Portaro
Former positions of Ross Portaro
Companies | Position | Start | End |
---|---|---|---|
TREX WIND-DOWN, INC. | Sales & Marketing | 31/12/2013 | 31/12/2015 |
Coherent Medical Group
Coherent Medical Group Medical SpecialtiesHealth Technology Part of Boston Scientific Corp., Coherent Medical Group is a private company that manufactures and markets electro-optical systems and medical instruments. The company is based in Santa Clara, CA. Coherent Medical Group was acquired by ESC Medical Systems Ltd. from Coherent, Inc. on April 30, 2001 for $259.24 million. | Corporate Officer/Principal | - | - |
CUTERA, INC. | Sales & Marketing | - | - |
Training of Ross Portaro
McIntire School of Commerce | Undergraduate Degree |
Statistics
International
United States | 6 |
Operational
Sales & Marketing | 3 |
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 5 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
CUTERA, INC. | Health Technology |
VENUS CONCEPT INC. | Health Technology |
Private companies | 2 |
---|---|
Coherent Medical Group
Coherent Medical Group Medical SpecialtiesHealth Technology Part of Boston Scientific Corp., Coherent Medical Group is a private company that manufactures and markets electro-optical systems and medical instruments. The company is based in Santa Clara, CA. Coherent Medical Group was acquired by ESC Medical Systems Ltd. from Coherent, Inc. on April 30, 2001 for $259.24 million. | Health Technology |
BioPharmX Corp.
BioPharmX Corp. BiotechnologyHealth Technology BioPharmX Corp. is a specialty pharmaceutical company focused on developing prescription products utilizing its proprietary HyantX Topical Delivery System for dermatology indications. The HyantX delivery system is designed to stabilize and solubilize hydrophilic molecules in an anhydrous gel environment. The company was founded by James R. Pekarsky and Anja B. Krammer on August 30, 2010 and is headquartered in Campbell, CA. | Health Technology |
- Stock Market
- Insiders
- Ross Portaro
- Experience